Literature DB >> 11819795

Inflammatory bowel disease in Estonia: a prospective epidemiologic study 1993-1998.

R Salupere1.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11819795      PMCID： PMC4688727          DOI： 10.3748/wjg.v7.i3.387

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN： 1007-9327            Impact factor:   5.742


× No keyword cloud information.
  6 in total

Review 1.  A critical review of epidemiological studies in inflammatory bowel disease.

Authors:  F Farrokhyar; E T Swarbrick; E J Irvine
Journal:  Scand J Gastroenterol       Date:  2001-01       Impact factor: 2.423

Review 2.  Epidemiology of inflammatory bowel disease: an update.

Authors:  M G Russel; R W Stockbrügger
Journal:  Scand J Gastroenterol       Date:  1996-05       Impact factor: 2.423

3.  Intestinal microflora of Estonian and Swedish infants.

Authors:  E Sepp; K Julge; M Vasar; P Naaber; B Björksten; M Mikelsaar
Journal:  Acta Paediatr       Date:  1997-09       Impact factor: 2.299

4.  Inflammatory bowel disease in Iceland, 1980-89. A retrospective nationwide epidemiologic study.

Authors:  S Björnsson; J H Johannsson; E Oddsson
Journal:  Scand J Gastroenterol       Date:  1998-01       Impact factor: 2.423

5.  Probiotic therapy fails to improve gut permeability in a hapten model of colitis.

Authors:  R J Kennedy; M Hoper; K Deodhar; S J Kirk; K R Gardiner
Journal:  Scand J Gastroenterol       Date:  2000-12       Impact factor: 2.423

6.  Antineutrophil cytoplasmic antibodies in Estonian patients with inflammatory bowel disease. Prevalence and diagnostic role.

Authors:  K Kull; R Salupere; R Uibo; M Ots; V Salupere
Journal:  Hepatogastroenterology       Date:  1998 Nov-Dec
  6 in total
  8 in total

Review 1.  An analysis of 10218 ulcerative colitis cases in China.

Authors:  Xue-Liang Jiang; Hui-Fei Cui
Journal:  World J Gastroenterol       Date:  2002-02       Impact factor: 5.742

2.  Striking elevation in incidence and prevalence of inflammatory bowel disease in a province of western Hungary between 1977-2001.

Authors:  Laszlo Lakatos; Gabor Mester; Zsuzsanna Erdelyi; Mihaly Balogh; Istvan Szipocs; Gyorgy Kamaras; Peter Laszlo Lakatos
Journal:  World J Gastroenterol       Date:  2004-02-01       Impact factor: 5.742

Review 3.  Is the incidence and prevalence of inflammatory bowel diseases increasing in Eastern Europe?

Authors:  L Lakatos; P L Lakatos
Journal:  Postgrad Med J       Date:  2006-05       Impact factor: 2.401

4.  NOD2, IL23R and ATG16L1 polymorphisms in Lithuanian patients with inflammatory bowel disease.

Authors:  Jurgita Sventoraityte; Aida Zvirbliene; Andre Franke; Ruta Kwiatkowski; Gediminas Kiudelis; Limas Kupcinskas; Stefan Schreiber
Journal:  World J Gastroenterol       Date:  2010-01-21       Impact factor: 5.742

Review 5.  Inflammatory bowel diseases: a disease (s) of modern times? Is incidence still increasing?

Authors:  Cristina Saro Gismera; Beatriz Sicilia Aladrén
Journal:  World J Gastroenterol       Date:  2008-09-28       Impact factor: 5.742

Review 6.  Biological therapy in inflammatory bowel diseases: access in Central and Eastern Europe.

Authors:  Fanni Rencz; Márta Péntek; Martin Bortlik; Edyta Zagorowicz; Tibor Hlavaty; Andrzej Śliwczyński; Mihai M Diculescu; Limas Kupcinskas; Krisztina B Gecse; László Gulácsi; Peter L Lakatos
Journal:  World J Gastroenterol       Date:  2015-02-14       Impact factor: 5.742

Review 7.  Recent trends in the epidemiology of inflammatory bowel diseases: up or down?

Authors:  Peter-Laszlo Lakatos
Journal:  World J Gastroenterol       Date:  2006-10-14       Impact factor: 5.742

8.  Effects of Rheum tanguticum polysaccharide on TNBS -induced colitis and CD4+T cells in rats.

Authors:  Li Liu; Zhi-Peng Wang; Chang-Tai Xu; Bo-Rong Pan; Qi-Bing Mei; Yin Long; Jia-Yun Liu; Si-Yuan Zhou
Journal:  World J Gastroenterol       Date:  2003-10       Impact factor: 5.742
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.